Scarica l'app Stockscreener
281.46
0.74%
2.06
Dopo l'orario di chiusura:
281.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LH Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Labcorp Holdings Inc Borsa (LH) Ultime notizie
Labcorp Holdings Inc. (LH) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Prepares to Report Q2 Earnings: What's in the Cards? - TradingView
Global Cancer Biomarkers Market to Reach $37.8 Billion by 2035 as Precision Oncology Adoption Accelerates - GlobeNewswire Inc.
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Labcorp Holdings Inc. (LH): Investor Outlook With A 10% Upside Potential - DirectorsTalk Interviews
Labcorp Holdings (LH) Q1 2026 Earnings Call Transcript - Fortune
Labcorp Holdings Inc. (N6B) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc (LH) Stock Up 3.7% but GF Value Says Overva - GuruFocus
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp To Pay $14.5M To Settle Medicare Fraud Allegations Over Unnecessary Drug Testing - Yahoo Finance
Diagnostics Co. Labcorp Settles FCA Claims For $14.5M - Law360
Labcorp seen as a steady growth buy with cost c... - Pluang
Laboratory Corporation of America (LH) Settles for $14.5M Over F - GuruFocus
Labcorp Holdings: The Story Has Not Changed Materially - Seeking Alpha
Labcorp to Pay $14.5 Million to Settle False Claims Act Allegations - marketscreener.com
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cell-Based Assay Services for Preclinical Use Only Global Market Report 2026 Released — Profiles Charles River, Labcorp, Eurofins and Evotec - Yahoo Finance
Baird Adjusts Labcorp Price Target to $338 From $335, Maintains Outperform Rating - marketscreener.com
Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Nigeria
Labcorp stock holds steady as diagnostics demand stays central - Ad Hoc News
What are Wall Street analysts' target price for Labcorp Holdings stock? - MSN
Labcorp stock steadies on its diagnostics and drug development mix - Ad-hoc-news.de
Labcorp Holdings Inc. (LH) Declares Cash Dividend of $0.72 Per S - GuruFocus
Labcorp Declares $0.72 Quarterly Dividend Payable September 2026 - Minichart
Labcorp Declares $0.72 Quarterly Dividend Payable Sept. 11 - TradingView
Labcorp (NYSE: LH) sets $0.72 per-share dividend payable September 11, 2026 - Stock Titan
Labcorp stock holds steady as investors await its next catalyst - Ad-hoc-news.de
Labcorp Declares Quarterly Dividend - AOL.com
Labcorp declares quarterly dividend of $0.72 per share - Investing.com
Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable Sept. 11 to Holders of Record Aug. 28 - marketscreener.com
Labcorp sets 72-cent dividend for Sept. 11 payout - Stock Titan
Here's what to expect from Labcorp Holdings’ next earnings report - MSN
Labcorp stock holds its business focus. Clinical diagnostics remain the core. - ad-hoc-news.de
Labcorp Holdings (LH) Expands Cancer And Liver Testing, Is It Fully Priced? - Sahm
Evercore ISI Adjusts Price Target on Labcorp to $315 From $300 - Moomoo
Labcorp EVP Bryan Vaughn sells $66,968 in common stock By Investing.com - Investing.com South Africa
Labcorp chief legal officer Kyle sells $26,329 in common stock. - Investing.com UK
Labcorp EVP Bryan Vaughn sells $66,968 in common stock - Investing.com UK
Form 4 Labcorp Holdings Inc For: 6 July By Investing.com - Investing.com Nigeria
Labcorp chief legal officer Kyle sells $26,329 in common stock. By Investing.com - Investing.com Australia
Form 4 Labcorp Holdings Inc For: 6 July - Investing.com India
Labcorp (NYSE: LH) legal chief sells shares, exercises 256 stock units - Stock Titan
Labcorp (LH) EVP sells shares after RSU vesting under Rule 10b5-1 plan - Stock Titan
Enterprise value to revenue forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating an 8.06% Potential Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Labcorp launches FDA-cleared blood test for Alzheimer's disease - MSN
1.45%
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):